Latest From Biotech Now

BioGENEius Challenge: The Very Real Students of BIO

BioGENEius

With the 2013 BioGENEius Challenge underway, we’ll soon find out who will be one of the new young leaders in the biotechnology industry. With younger generations growing increasingly civic minded and looking to affect their communities by finding first-rate solutions to food, climate and health challenges, the BioGENEius Challenge fosters the best, smartest and most skilled workers who aim to tackle these issues and pursue a career in biotechnology. The BioGENEius International Challenge is one of the Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , , , ,

Twenty Years & Counting: Welcome to Chicago!

Jim Greenwood

Welcome to the 2013 BIO International Convention. It is hard to believe, but this year BIO reaches a significant milestone as we celebrate 20 years of bringing innovation, opportunity and growth to an industry that heals, fuels and feeds the world. From a small beginning – less than 1,500 people attended the first BIO meeting in 1993 – our Convention has grown into the most influential biotech gathering in the world, attracting thousands of industry Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Approving Drugs for Alzheimer’s Disease

Russ Katz

BIOtechNOW delves into the current state of Alzheimer’s disease research with today’s feature on regulatory challenges. Tomorrow, we cover the first Alzheimer’s prevention trial, and on Wednesday, we will explore the societal and economic impact of this devastating disease. The therapies currently approved for Alzheimer’s disease work by treating the patients’ symptoms, improving their cognitive and overall functions. Increasingly, however, experts are intent on slowing or halting the disease process—before it has ravaged patients’ brains. In February, the U.S. Food Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Crowdfunding Goes Viral

Crowdfunding

Is crowdfunding a viable source of capital for biotech companies? μBiome thinks so; they are a startup biotech company that raised $351,193. They asked for $100,000. That’s right; over three times their goal. “[Crowdfunding for biotech] is an idea whose time has come,” says μBiome’s CEO Jessica Richman. “The fact that we did it is proof of that. We’re the first ones but there will be lots of others.” Is there a way that crowdfunding could help Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Biotechnology Helps Meet Consumer Demand for Earth-Friendly Products

Bottle

Industrial biotechnology has its roots in cleaning up environmental hazards. In fact, the first patented genetically engineered microbe was designed to clean up oil spills. Today, biotechnology enables manufacturers to make sustainable products with renewable material, instead of oil, and to use less energy in the manufacturing process A recent Roundtable discussion hosted by the Industrial Biotechnology Journal and printed in its April edition features academic experts and executives from industrial biotechnology and consumer product Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , ,